Frontlight ResearchEarly access
CompletedNo phase
Study of Multifrequential Impedancemetry in Pulsatile Tinnitus
Key facts
- Who runs it
- University Hospital, Bordeaux
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 3 Jun 2024
- Ended
- 4 Sept 2025
- Type of study
- Observational
- Treatments tested
- multifrequential admittancemetry
- Record updated
- 6 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Adult patient
- Unilateral or bilateral pulsatile tinnitus
- Pulsatile tinnitus > 1 month old
- Affiliated or beneficiary of by social security system
Who cannot take part
- Otological surgery, excluding trans-tympanic aerators in childhood with closed eardrum
- Middle ear abnormality (any type of partial or total filling of the middle ear) noted on otoscopy or subsequent MRI scan
- Abnormal eardrums excluding tympanosclerosis
- Non-pulsatile tinnitus
- Conductive hearing loss with abolition of stapedial reflexes
- Minor patient
- Major protected
- Abnormal tympanometry at 226 Hz
- Presence of rotatory vertigo
- Opposition to participation expressed by patient
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study intended to search for a relationship between the multifrequential admittancemetry and the pulsatile tinnitus.
The group in the trial
- patient with pulsatile tinnitus
Treatment: multifrequential admittancemetry
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 6 March 2026